Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  BUCHAREST STOCK EXCHANGE  >  Antibiotice SA    ROATB   ROATBIACNOR9

ANTIBIOTICE SA (ROATB)
Mes dernières consult.
Most popular
Report
 SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
Financials ( RON)
Sales 2017 369 M
EBIT 2017 42,8 M
Net income 2017 -
Debt 2017 -
Yield 2017 -
Sales 2018 -
EBIT 2018 -
Net income 2018 -
Debt 2018 -
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018 -
Capi. / Sales2017 0,99x
Capi. / Sales2018 -
Capitalization 364 M
More Financials
Company
Antibiotice SA is engaged in the research, development and manufacture of pharmaceutical products.The company is involved in the production of injectable cephalosporins and anti-infectives.Its products include powders for injectable solutions and suspensions, capsules tablets, ointments, gels,... 
Sector
Pharmaceuticals
Calendar
11/15Earnings Release
More about the company
Latest news on ANTIBIOTICE SA
10/16 ANTIBIOTICE : (RO) Raport curent sistare dividende 2013 2017-10-16
09/05 ANTIBIOTICE : Cureent report 2017-08-14
08/31 ANTIBIOTICE SA : ex-dividend day for annual dividend
06/14 ANTIBIOTICE : Play, joy, music and creation on the Children’s Day to Antib..
05/30 ANTIBIOTICE : marks the World Environment Day
05/26 ANTIBIOTICE : Primary school children visit Antibiotice
05/15 BURSA DE VALORI BUCURESTI : Antibiotice Iasi exports up 21 pct in Q1
05/15 ANTIBIOTICE : (RO) Comunicat disponibilitate – Rezultate financiare Tirmes..
04/05 ANTIBIOTICE : supports the campaign „End tuberculosis. Now and forever!&rd..
02/15 ANTIBIOTICE : (RO) Comunicat disponibilitate – Rezultate preliminare 2016 ..
More news
Sector news : Pharmaceuticals - NEC
06:27p JOHNSON & JOHNSON : California judge tosses $417 million talc cancer verdict aga..
10/20DJMERCK AND : to Lay Off About 1,800 U.S. Sales Reps in Cost-Cutting Move
10/20 MERCK AND : to cut 1,800 U.S. sales jobs, add 960 in chronic care
10/20DJABBOTT LABORATORIES : Hacking Is a Risk for Pacemakers. So Is the Fix
10/19DJCELGENE : Halts Crohn's Disease Drug Trials
More sector news : Pharmaceuticals - NEC
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 1
Average target price 0,64  RON
Spread / Average Target 18%
Managers
NameTitle
Ioan Nani Vice Chairman & Chief Executive Officer
Ionut Sebastian Iavor Chairman
Paula-Luminita Coman Economic Director
Cornelia Moraru Director-Technical & Production
Mihaela Mosnegutu Medical Director
Sector and Competitors
1st jan.Capitalization (M$)
ANTIBIOTICE SA93
JOHNSON & JOHNSON23.29%382 202
NOVARTIS13.50%226 404
PFIZER11.58%216 886
ROCHE HOLDING LTD.5.55%207 116
MERCK AND COMPANY7.88%174 223